TC TECH received an order in the biotechnology sector from Israel-based diagnostics company Picodya Technologies Ltd. (Picodya)
TC TECH Sweden AB (publ) announces that the company has received an order valued at approx. 6.5 MSEK covering production system and equipment for manufacturing of consumable products within microfluidics/diagnostics. The customer will be using TC TECH’s technology in its research and development activities, with the aim to integrate it in commercial solutions.
Picodya is an innovative diagnostics company, which develops solutions to enable rapid and cost effectiveness in vitro diagnostics directly at point of care facilities (POC). Each diagnostic testing for a patient requires the use of advanced consumable products, which needs to be manufactured with high precision to secure efficient and reliable diagnostics.
”I am pleased to present TC TECH’s first order in the biotechnology sector, and it’s also very suitably coming from a European based company. To be selected as technology provider to an innovative diagnostics company as Picodya is an interesting step for TC TECH and we will be looking forward to further developing our technology together with Picodya for applications within this market segment,” says TC TECH’s CEO Alexander Luiga.
The order includes a TCP150 HPE RtS production system with expected delivery to the customer already during the end of the second quarter of 2022. The parties have also initiated discussions on a collaboration agreement to further enhance TC TECH’s production technology, with a focus on applications within microfluidics. TC TECH has a positive view on this opportunity to potentially further develop the company’s offering in this exciting market segment.
